Medication-Assisted Treatment (MAT) Training
Medication-assisted treatment (MAT) to help people reduce or quit their use of heroin or other opiates, such as pain relievers, is carefully regulated. Qualified physicians, nurse practitioners and physician assistants are required to acquire a waiver and maintain certifications to legally dispense or prescribe opioid dependency medications. Idaho desperately needs more providers to offer this important treatment in their practice.
MAT Wavier Training hosted by ECHO Idaho
ECHO Idaho is hosting a training for physicians, nurse practitioners and physician assistants who want to get their MAT waiver to prescribe and dispense buprenorphine.
Tuesday, April 23, 2019
12:30-5 p.m. MT
The two-part training includes:
- A live 4-hour seminar which participants can join using ECHO video conferencing technology
- Online modules you complete on your own. The link to the online half will be sent to those who complete the live training
Both portions of the training are free and approved for 8 credits of CME (see "More CME Information"). Physicians who complete the training will qualify for the waiver to prescribe and dispense buprenorphine. Nurse practitioners and physicians assistants will also qualify for the waiver after an additional 16 hours of training.
RSVP for the training by filling out our form. If you RSVP you will receive reminders and more information leading up to the training.
Dr. Magni Hamso, MD MPH
General Internist, Terry Reilly Health Services
Associate Program Director, University of Washington - Boise Internal Medicine Residency
Dr. Todd Palmer, MD
Family Medicine and Addiction Medicine
Lead faculty and Geriatric and Addiction Medicine Curriculum Coordinator, Family Medicine Residency of Idaho
Dr. Alicia Carrasco, MD
General Internist, Boise VA
At the conclusion of this activity participants should be able to:
- Review addiction treatment in office- based practices
- Discuss the pharmacological treatments of opioid use disorder
- Determine what medical record documentation must be followed
- Discuss the process of buprenorphine induction as well as stabilization and maintenance techniques
- Describe how to take a patient history and evaluation
- Review safety concerns and drug interactions
More CME Information
CME Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AAAP and University of Idaho. AAAP is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation: American Academy of Addiction Psychiatry designates this Other activity (“Half and Half” - Half face-to-face live course and Half online course) for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Method of physician participation in the learning process: Credit will only be awarded for completing both the “first” and the “second” half of the training. To be awarded a maximum of 8 AMA PRA Category 1 Credits™ and a Buprenorphine Training Completion Certificate you must complete 4.25 hours of the first live half and 3.75 hours of the second enduring half and receive a minimum cumulative score of 75% on the examination. No partial credit is awarded for this training.
AAAP is the Data Sponsor for this training.
Funding for this initiative was made possible (in part) by grant no. 5U79TI026556 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
ECHO Idaho is led by the University of Idaho and WWAMI.